相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Frank L. J. Visseren et al.
EUROPEAN HEART JOURNAL (2021)
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia
Bianca Rocca et al.
BLOOD (2020)
The COMPASS Trial Net Clinical Benefit of Low-Dose Rivaroxaban Plus Aspirin as Compared With Aspirin in Patients With Chronic Vascular Disease
Jan Steffel et al.
CIRCULATION (2020)
Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease
Sameer Bansilal et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Once versus twice daily aspirin after coronary bypass surgery: a randomized trial
J. S. Paikin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease
Jean-Guillaume Dillinger et al.
AMERICAN HEART JOURNAL (2012)
Antiplatelet Drugs Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
John W. Eikelboom et al.
CHEST (2012)
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes
B. Rocca et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications
Galia Spectre et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Association of Cyclooxygenase-1-Dependent and -Independent Platelet Function Assays With Adverse Clinical Outcomes in Aspirin-Treated Patients Presenting for Cardiac Catheterization
Andrew L. Frelinger et al.
CIRCULATION (2009)
Aspirin resistance in Indian patients with coronary artery disease and cardiovascular events
V. S. Thomson et al.
JOURNAL OF POSTGRADUATE MEDICINE (2009)
Aspirin resistance measured by cationic propyl gallate platelet aggregometry and recurrent cardiovascular events during 4 years of follow-up
D. Stejskal et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2006)
Variability in response to aspirin: do we understand the clinical relevance?
CL Campbell et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Expert consensus document on the use of antiplatelet agents - The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology
C Patrono et al.
EUROPEAN HEART JOURNAL (2004)
分享论文
